New Medicine - A Comprehensive Information and Consulting Service  
HOME PRODUCTS & SERVICES ORDER/INQUIRY PRESS RELEASES EMPLOYMENT CONTACT US

Future Oncology - Technology, Products, Markets, and Service Opportunities

* Requires Adobe Acrobat Reader

FUTURE ONCOLOGY - TECHNOLOGY, PRODUCTS, MARKETS, AND SERVICE OPPORTUNITIES IN THE CANCER FIELD

FUTURE ONCOLOGY
Volume 7 #10/11 February 2004


STATE-OF-THE-ART IN THE MANAGEMENT OF CANCER

PANCREATIC CANCER PART II
CURRENT DISEASE MANAGEMENT APPROACHES AND COMBINATION CHEMOTHERAPY/MULTIMODALITY CLINICAL TRIALS OF COMMERCIALLY AVAILABLE ANTICANCER AGENTS

CURRENT TREATMENT MODALITIES
  • Surgery
  • Radiation Therapy (RT)
    • External beam radiation therapy (EBRT)/3-dimensional conformal RT (3D-CRT)
    • Intensity-modulated radiation therapy (IMRT)
    • Intraoperative radiation therapy (IORT)
    • Interstitial brachytherapy
    • Image-guided, ractionated, stereotactic radiosurgery
  • Chemotherapy
    • 5-Fluorouracil (5-FU)
    • Arsenic trioxide
    • Capecitabine
    • Celecoxib
    • Cisplatin
    • Docetaxel
    • Gemcitabine
    • Irinotecan
    • Ocreotide acetate
    • Oxaliplatin
    • Virulizin
  • Hyperthermia
  • Photodynamic Therapy (PDT)
  • Electroporation Therapy (EDT)

TREATMENT BY STAGE

  • Resectable Locally Advanced Disease
    • Adjuvant Chemotherapy/CRT
  • Inoperable Locally Advanced Disease
    • Chemoradiotherapy (CRT)
    • Intraoperative radiation therapy (IORT)
  • Metastatic Disease
  • Pain Management

TREATMENT COSTS


LIST OF EXHIBITS

Exhibit 1 - Interim and Final Results from Selected Clinical Trials with Approved Chemotherapy Agents in Combination and Multimodality Regimens in Pancreatic Cancer

Exhibit 2 - Worldwide Incidence of Pancreatic Cancer in 2002


HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US

NEW MEDICINE, INC.
PHONE: 949-830-0448   FAX: 949-830-0887